Skip to main content

Table 1 Characteristics of TA patients

From: Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis

 

Total

Active

Inactive

p

N

84

47

37

 

Sex, female (%)

73 (86.90)

40 (85.11)

33 (89.19)

0.415

Age, years

31.88 ± 10.01

29.64 ± 8.78

34.73 ± 10.86

0.023

Disease duration, months

47.49 ± 66.03

34.96 ± 5.10

84.34 ± 13.87

0.001

Clinical manifestations

 Hypertension (%)

20 (23.81)

7 (14.89)

13 (35.14)

0.029

 Asymmetrical blood pressure (%)

3 (3.57)

3 (6.38)

0

0.170

 Pulseless (%)

6 (7.14)

6 (12.77)

0

0.032

 Fatigue (%)

7 (8.33)

7 (14.89)

0

0.016

 Dizziness (%)

9 (10.71)

8 (17.02)

1 (2.70)

0.035

 Neck pain (%)

14 (16.67)

14 (29.79)

0

< 0.001

 Fever (%)

3 (3.57)

3 (6.38)

0

0.170

Received therapies (%)

49 (58.33)

20 (42.55)

29 (78.38)

0.001

Laboratory examination

 ESR, mm/H

37.46 ± 32.95

50.72 ± 34.55

20.53 ± 21.25

< 0.001

 CRP, mg/L

27.13 ± 44.19

41.37 ± 53.85

8.53 ± 11.66

0.001

 SAA, mg/L

99.71 ± 176.38

144.01 ± 212.72

32.29 ± 52.87

0.017

 Platelet count, ×109/L

301.23 ± 110.81

327.85 ± 123.58

267.22 ± 81.64

0.013

 Kerr scores

1.89 ± 1.05

2.40 ± 0.92

1.24 ± 0.83

< 0.001

 ITAS 2010 scores

3.43 ± 4.73

4.68 ± 4.93

1.84 ± 3.98

0.004

Ultrasound index

 Carotid artery wall thickness, mm

2.12 ± 0.77

2.36 ± 0.86

1.79 ± 0.49

0.001

 Carotid artery diameter, mm

3.73 ± 2.19

3.91 ± 1.92

3.48 ± 2.51

0.424

 Diffuse lesions (%)

72 (85.71)

40 (85.11)

32 (86.49)

0.557

 Proportions of vascular stenosis (%)

59 (70.24)

29 (61.70)

30 (81.08)

0.044

 Proportions of vascular occlusion (%)

10 (11.90)

2 (4.26)

8 (21.62)

0.019

 Carotid artery peak flow rate, m/s

1.37 ± 0.99

1.59 ± 1.04

1.08 ± 0.85

0.019

 Carotid RI

0.73 ± 0.13

0.73 ± 0.13

0.72 ± 0.13

0.915

 CEUS carotid wall vascularization grade 2 (%)

38 (45.24)

29 (61.70)

9 (24.32)

0.001

  1. TA Takayasu arteritis, ESR erythrocyte sedimentation rate, CRP C-reactive protein, SAA serum amyloid A, RI resistance index, CEUS contrast-enhanced ultrasonography